Dengue is an emerging viral disease principally transmitted by the Aedes (Stegomyia)
aegypti mosquito. It is one of the fastest-growing global infectious diseases, with 100–400 …

Greater human mobility, largely driven by air travel, is leading to an increase in the
frequency and reach of infectious disease epidemics. Air travel can rapidly connect any two …

For dengue viruses 1 to 4 (DENV1-4), a specific range of antibody titer has been shown to
enhance viral replication in vitro and severe disease in animal models. Although suspected …

Dengue virus causes approximately 96 million symptomatic infections annually, manifesting
as dengue fever or occasionally as severe dengue,. There are no antiviral agents available …

Dengue fever is the most important mosquito-borne viral disease in Southeast Asia.
Insecticides remain the most effective vector control approach for Aedes mosquitoes. Four …

The pandemic spread of a novel coronavirus–SARS coronavirus-2 (SARS-CoV-2) as a
cause of acute respiratory illness, named Covid-19, is placing the healthcare systems of …

As with many pathogens, most dengue infections are subclinical and therefore unobserved.
Coupled with limited understanding of the dynamic behaviour of potential serological …

Background Oropouche virus is an arthropod-borne virus that has caused outbreaks of
Oropouche fever in central and South America since the 1950s. This study investigates …

Between October 2013 and April 2014, more than 30,000 cases of Zika virus (ZIKV) disease
were estimated to have attended healthcare facilities in French Polynesia. ZIKV has also …

The first approved dengue vaccine has now been licensed in six countries. We propose that
this live attenuated vaccine acts like a silent natural infection in priming or boosting host …